Daniel Clair to United States
This is a "connection" page, showing publications Daniel Clair has written about United States.
Connection Strength
0.275
-
PROMISE I: Early feasibility study of the LimFlow System for percutaneous deep vein arterialization in no-option chronic limb-threatening ischemia: 12-month results. J Vasc Surg. 2021 11; 74(5):1626-1635.
Score: 0.079
-
The EPIC nitinol stent system in the treatment of iliac artery lesions: one-year results from the ORION clinical trial. J Endovasc Ther. 2014 Apr; 21(2):213-22.
Score: 0.048
-
Prospective, multicenter experience with the Ventana Fenestrated System for juxtarenal and pararenal aortic aneurysm endovascular repair. J Vasc Surg. 2013 Jul; 58(1):1-9.
Score: 0.045
-
Neuroprotection during carotid artery stenting using the GORE flow reversal system: 30-day outcomes in the EMPiRE Clinical Study. Catheter Cardiovasc Interv. 2011 Feb 15; 77(3):420-9.
Score: 0.038
-
Failure on a Vascular Surgery Board-American Board of Surgery Examination does not predict cardiovascular outcomes in the Society for Vascular Surgery Vascular Quality Initiative. J Vasc Surg. 2020 11; 72(5):1753-1760.
Score: 0.018
-
Interim Results of the PROMISE I Trial to Investigate the LimFlow System of Percutaneous Deep Vein Arterialization for the Treatment of Critical Limb Ischemia. J Invasive Cardiol. 2019 03; 31(3):57-63.
Score: 0.017
-
Centers for Medicare & Medicaid Services' decision on drug-coated balloons: No additional reimbursement despite higher cost and highest levels of scientific evidence. Vasc Med. 2018 12; 23(6):558-559.
Score: 0.017
-
Effective endovascular treatment of calcified femoropopliteal disease with directional atherectomy and distal embolic protection: final results of the DEFINITIVE Ca?? trial. Catheter Cardiovasc Interv. 2014 Aug 01; 84(2):236-44.
Score: 0.012